MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-22-0026224
Rimo Pharmaceuticals Private Limited
Rimo Pharmaceuticals Private Limited - pharma in Mysore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.53 Cr
▲ 28% YoY
Net loss · FY 2025
₹4.45 Lakh
Net margin -1.3%
EBITDA · FY 2025
₹14.89 Lakh
EBITDA margin 4.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹52.92 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
4
As per MCA filings
About Rimo Pharmaceuticals Private Limited
Data last updated:
Rimo Pharmaceuticals Private Limited is a private limited company based in Mysore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U52609KA2019PTC123353. Its GSTIN is 29AAJCR5376G1ZV (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nandakumar Bhuvaneshwari and Bilaguli Renukananda Divya.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 4251 Ground Floor Shop No 3 3rd Stage Dattagalli, Mysore, Karnataka, India – 570033.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.53 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net loss of ₹4.45 Lakh (net margin -1.3%) and EBITDA of ₹14.89 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 120% over five years.
As per MCA filings, the company has open charges of ₹52.92 Lakh on record.
Rimo Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-22-0026224).
Company details
CIN U52609KA2019PTC123353
Registration Number 123353
Incorporation Date 10 April 2019
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-KR-22-0026224
Key People
Nandakumar Bhuvaneshwari Director Bilaguli Renukananda Divya Director Girish Basavaraju Director Recognitions & Rankings of Rimo Pharmaceuticals
Contact details
Rimo Pharmaceuticals Private Limited's registered office is in Mysore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo 4251 Ground Floor Shop No 3 3rd Stage Dattagalli, Mysore, Karnataka, India – 570033
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rimo Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Rimo Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rimo Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Rimo Pharmaceuticals Private Limited, buy the company report.
Financials of Rimo Pharmaceuticals Private Limited
FY 2025 filings availableRimo Pharmaceuticals Private Limited reported revenue of ₹3.53 Cr (up 28% YoY) for FY 2025.
Revenue · FY 2025
₹3.53 Cr ▲ 28%
Net loss · FY 2025
₹4.45 Lakh margin -1.3%
EBITDA · FY 2025
₹14.89 Lakh margin 4.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 43%
5 years · compounded
▲ 120%
EBITDA CAGR growth
1 year
▲ 162%
3 years · compounded
▲ 121%
5 years · compounded
▲ 99%
Revenue has grown at a compounded annual rate (CAGR) of 120% over five years, including 28% growth in the latest year. EBITDA rose 162% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | -1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rimo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rimo Pharmaceuticals Private Limited
Rimo Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandakumar Bhuvaneshwari | Director | 30 Dec 2023 | 2 Years 10 Months | Current |
| Bilaguli Renukananda Divya | Director | 30 Dec 2023 | 2 Years 10 Months | Current |
| Girish Basavaraju Also directs: Nectamed Laboratories LLP, Akihiro Pharmaceuticals Private Limited | Director | 10 Apr 2019 | 7 Years 6 Months | Current |
| Thuraganur Mahadevu Manjunath Also directs: Nectamed Laboratories LLP, Akihiro Pharmaceuticals Private Limited | Director | 10 Apr 2019 | 7 Years 6 Months | Current |
Auditor
Rimo Pharmaceuticals Private Limited is audited by SUBEK AGARWAL & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUBEK AGARWAL & ASSOCIATES | FY 2021 | 328737E |
Shareholding
The shareholding of Rimo Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Rimo Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹52.92 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Dec 2023 | 100836461 | Axis Bank Limited | ₹43.42 Lakh | Open | |
| 25 Jun 2022 | 100602341 | Karnataka Bank Ltd. | ₹9.5 Lakh | Open |
To see the full charge records of Rimo Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Rimo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rimo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rimo Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAJCR5376G1ZV | Karnataka | Active | 06 Nov 2019 |
To see the full GST registrations and return filing status of Rimo Pharmaceuticals Private Limited, buy the company report.
Recent activity
Rimo Pharmaceuticals Private Limited has 4 board changes on record since 2019: 4 appointments. The latest: Bilaguli Renukananda Divya was appointed as Director on 30 Dec 2023.
AGM
Rimo Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Rimo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Bilaguli Renukananda Divya was appointed as Director.
Appointed
Nandakumar Bhuvaneshwari was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 43.42 Lakh with Charge ID 100836461 was registered on 26 Dec 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 9.50 Lakh with Charge ID 100602341 was registered on 25 Jun 2022.
Charges
A charge with Karnataka Bank Ltd. of Rs. 9.50 Lakh registered on 25 Jun 2022 with Charge ID 100602341 was modified on 25 Jun 2022.
Appointed
Girish Basavaraju was appointed as Director.
Appointed
Thuraganur Mahadevu Manjunath was appointed as Director.
Incorporation
10 Apr 2019
Rimo Pharmaceuticals Private Limited was registered on 10 Apr 2019 with Roc Bangalore & aged 7 years 6 months as per MCA records.
Frequently asked questions
Rimo Pharmaceuticals is an active private limited company based in Mysore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 April 2019 (7+ years old) and is registered under CIN U52609KA2019PTC123353.
Rimo Pharmaceuticals has 4 current directors:
- Nandakumar Bhuvaneshwari - Director
- Bilaguli Renukananda Divya - Director
- Girish Basavaraju - Director
- Thuraganur Mahadevu Manjunath - Director
The latest financial statements of Rimo Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Rimo Pharmaceuticals is 29AAJCR5376G1ZV, registered in Karnataka.
The CIN (Corporate Identification Number) of Rimo Pharmaceuticals is U52609KA2019PTC123353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rimo Pharmaceuticals was incorporated on 10 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
Bilaguli Renukananda Divya was appointed as Director on 30 Dec 2023. Nandakumar Bhuvaneshwari was appointed as Director on 30 Dec 2023. Girish Basavaraju was appointed as Director on 10 Apr 2019. Rimo Pharmaceuticals has 4 board changes on record in total.
Yes, Rimo Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-22-0026224).
The registered office of Rimo Pharmaceuticals is at No 4251 Ground Floor Shop No 3 3rd Stage Dattagalli, Mysore, Karnataka, India – 570033.
Rimo Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages